Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients
Clinical trial NCT03137264 · COMPLETED
Trial details
- NCT number
- NCT03137264
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-24
- Primary completion
- 2018-11-10
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.